has been cited by the following article(s):
[1]
|
Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis
Critical Reviews in Oncology/Hematology,
2019
DOI:10.1016/j.critrevonc.2019.102818
|
|
|